As women navigate midlife and menopause, understanding how their bodies utilize essential nutrients like vitamin D3 and K2 becomes increasingly relevant. While diet and lifestyle play significant roles, individual genetic variations can also influence how effectively these vitamins are absorbed and utilized.
This article explores the current understanding of how genetic factors might impact your response to vitamin D3 and K2. We will focus on key genes involved in their pathways, offering insights into why individual responses to supplementation can sometimes vary.
The Role of Vitamin D: Beyond Bone Health
Vitamin D, often referred to as the ‘sunshine vitamin,’ is critical for various bodily functions, extending beyond its well-known role in bone health. It supports immune function and cellular processes throughout the body. However, the effectiveness of vitamin D can be influenced by how the body processes it, a mechanism that can be impacted by genetic variations.
When we discuss the ‘response’ to vitamin D, we are often referring to how well the body can activate it and how effectively its active form interacts with target cells. This interaction is mediated by a protein called the vitamin D receptor (VDR).
Vitamin D Receptor (VDR) Gene Polymorphisms: A Key Player
The vitamin D receptor (VDR) is a protein that binds to active vitamin D, initiating a cascade of genetic expression that influences numerous physiological processes. Variations, or polymorphisms, within the VDR gene can alter the structure or function of this receptor, potentially affecting how an individual responds to vitamin D.
Research suggests that VDR gene polymorphisms have been associated with various health considerations. For example, specific VDR gene polymorphisms have been explored in relation to essential hypertension [1] and the risk of sepsis [2]. Other studies have looked at associations with atopy [3], asthma susceptibility [4], and nephrolithiasis [5]. Furthermore, VDR gene polymorphisms have been investigated in the context of vitamin D supplementation and outcomes in tuberculosis [6]. These findings indicate that genetic differences in the VDR gene may contribute to variations in individual responses to vitamin D and its broader health impacts.
Understanding Vitamin K2 and Its Metabolism
Vitamin K2, particularly the menaquinone forms, plays a crucial role in calcium metabolism, directing calcium to bones and teeth and away from soft tissues. Its activity is closely linked with vitamin D3, as D3 helps produce vitamin K-dependent proteins, which then require K2 for activation. The metabolism and utilization of vitamin K2 in the body are also subject to genetic influences.
One key enzyme involved in vitamin K metabolism is vitamin K epoxide reductase complex subunit 1 (VKORC1). This enzyme is essential for recycling vitamin K after it has participated in activating K-dependent proteins. Variations in the gene encoding VKORC1 can impact how efficiently vitamin K is recycled and utilized.
Specific forms of vitamin K, such as phylloquinone (K1), menaquinone (MK4, MK7), and menadione (K3), interact with VKORC1 [7]. Research has explored how VKORC1 polymorphism may affect the atypical absorption of menatetrenone (MK4) and its metabolism [8]. This suggests that genetic variations in VKORC1 could influence the bioavailability and effectiveness of different forms of vitamin K2.
VKORC1 Gene Polymorphisms and Individual Responses
Polymorphisms in the VKORC1 gene can alter the enzyme’s activity, potentially leading to individual differences in vitamin K requirements and how the body responds to vitamin K intake. For example, variations in the VKORC1 gene have been investigated as a determinant of differences in COVID-19-related disease severity [9]. This highlights that genetic variations impacting vitamin K metabolism can have wide-ranging implications.
While the interaction between VKORC1 polymorphisms and vitamin K2 supplementation specifically for bone and cardiovascular health in midlife women is an area of ongoing research, the existing evidence indicates that genetic factors can influence vitamin K metabolism. One study, for instance, examined serum undercarboxylated osteocalcin as a biomarker of vitamin K intake and its association with prostate cancer risk [10], underscoring the importance of vitamin K status and the potential for genetic influences on its markers.
Connecting D3 and K2: A Genetic Perspective
Given that vitamin D3 and K2 often work synergistically, understanding how genetic variations in both the VDR and VKORC1 genes might collectively influence an individual’s response to supplementation is complex. For women in midlife and menopause, who are often focused on bone density and cardiovascular wellness, these genetic insights may offer a more personalized approach to nutrient support.
While direct research on the combined impact of VDR and VKORC1 polymorphisms on D3+K2 supplementation outcomes in midlife women is still developing, the individual evidence for each gene suggests that genetic predispositions can play a role in nutrient utilization. This area of research is evolving, and future studies may provide more specific guidance.
References
- Association between vitamin D receptor gene polymorphism and essential hypertension: An updated systematic review, meta-analysis, and meta-regression. PloS one, 2024
- Association of vitamin D receptor gene polymorphism with the risk of sepsis: A systematic review and meta-analysis. Medicine, 2023
- Vitamin D receptor gene polymorphisms in atopy. Immunity, inflammation and disease, 2021
- Vitamin D receptor gene polymorphism and susceptibility to asthma: Meta-analysis based on 17 case-control studies. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020
- Association of Vitamin D Receptor Gene Polymorphism With the Risk of Nephrolithiasis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2019
- Vitamin D receptor gene polymorphism and vitamin D supplementation on clinical/ treatment outcome in tuberculosis: current and future perspectives. Expert review of anti-infective therapy, 2022
- Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1. Nutrients, 2019
- Modelling the atypical absorption of menatetrenone and the metabolism to its epoxide: effect of VKORC1 polymorphism. Journal of clinical pharmacy and therapeutics, 2011
- Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity. Medical hypotheses, 2020
- Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
